[go: up one dir, main page]

WO2006125810A3 - Composition pour retarder le développement de la maladie d'alzheimer - Google Patents

Composition pour retarder le développement de la maladie d'alzheimer Download PDF

Info

Publication number
WO2006125810A3
WO2006125810A3 PCT/EP2006/062608 EP2006062608W WO2006125810A3 WO 2006125810 A3 WO2006125810 A3 WO 2006125810A3 EP 2006062608 W EP2006062608 W EP 2006062608W WO 2006125810 A3 WO2006125810 A3 WO 2006125810A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
alzheimer
disease
development
slowing down
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/062608
Other languages
English (en)
Other versions
WO2006125810A2 (fr
Inventor
Dominique Bourgeade
Jean-Christophe Anton
Francois Miceli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COTHERA
Original Assignee
COTHERA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTHERA filed Critical COTHERA
Priority to EP06755300A priority Critical patent/EP1890689A2/fr
Priority to US11/921,066 priority patent/US20090181974A1/en
Publication of WO2006125810A2 publication Critical patent/WO2006125810A2/fr
Publication of WO2006125810A3 publication Critical patent/WO2006125810A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention consiste en une composition comprenant : - une huile végétale contenant au moins un acide linoléique et au moins un acide linolénique, - de la vitamine E, - de la vitamine B9 (ou de folates), le rapport pondéral acide linoléique/acide linolénique étant compris entre 3 et 5. La composition selon l'invention a pour objet de retarder le développement de la maladie d'Alzheimer et d'améliorer la qualité de vie des patients. Cette composition est destinée à être incorporée à un vecteur assimilable par le corps humain, de préférence par la voie alimentaire.
PCT/EP2006/062608 2005-05-27 2006-05-24 Composition pour retarder le développement de la maladie d'alzheimer Ceased WO2006125810A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06755300A EP1890689A2 (fr) 2005-05-27 2006-05-24 Composition pour retarder le développement de la maladie d'alzheimer
US11/921,066 US20090181974A1 (en) 2005-05-27 2006-05-24 Composition for slowing down the development of alzheimer's disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0505365A FR2886154B1 (fr) 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer
FR0505365 2005-05-27

Publications (2)

Publication Number Publication Date
WO2006125810A2 WO2006125810A2 (fr) 2006-11-30
WO2006125810A3 true WO2006125810A3 (fr) 2007-05-10

Family

ID=35466542

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/062608 Ceased WO2006125810A2 (fr) 2005-05-27 2006-05-24 Composition pour retarder le développement de la maladie d'alzheimer

Country Status (4)

Country Link
US (1) US20090181974A1 (fr)
EP (1) EP1890689A2 (fr)
FR (1) FR2886154B1 (fr)
WO (1) WO2006125810A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2568826A4 (fr) * 2010-05-13 2014-03-26 Nitromega Corp Acides gras nitrés, neuroprotection et/ou inhibition du déclin cognitif
TWI829098B (zh) 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物
TWI788111B (zh) 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
US10137164B2 (en) * 2015-01-02 2018-11-27 Melaleuca, Inc. Dietary supplement compositions

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB806714A (en) * 1956-05-03 1958-12-31 Merck Ag E Improvements in or relating to pharmaceuticals
FR2292437A1 (fr) * 1974-11-27 1976-06-25 Otc Consult Ab Procede pour la preparation d'un aliment pour coquillages et poissons
FR2497068A1 (fr) * 1980-12-27 1982-07-02 Snow Brand Milk Products Co Ltd Composition nutritive adaptee a une alimentation par voie enterale
FR2520232A1 (fr) * 1982-01-22 1983-07-29 Ajinomoto Kk Regime elementaire pour les maladies hepatiques
EP0126666A1 (fr) * 1983-04-20 1984-11-28 Roussel-Uclaf Nouvelles compositions utilisables en diététique, réanimation et thérapeutique, renfermant une fraction protéique à base de 3 types de minipeptides et leurs applications
EP0330583A2 (fr) * 1988-02-26 1989-08-30 L'oreal Méthode pour améliorer l'aspect esthétique de la peau à l'aide de mélanges polyvitaminiques et compositions cosmétiques pour sa mise en oeuvre
FR2691616A1 (fr) * 1992-05-27 1993-12-03 Thorel Jean Noel Bio-vecteurs nutritionnels.
FR2706255A1 (fr) * 1993-06-17 1994-12-23 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
US5455235A (en) * 1992-04-10 1995-10-03 Otsuka Pharmaceutical Co., Ltd. Food composition for inhibiting the formation of an intestinal putrefactive product
EP0689834A2 (fr) * 1994-07-01 1996-01-03 Willem Jacob Serfontein Additif alimentaire pour l'homme ou les animaux contenant des vitamines et des sels minéraux à libération prolongée
EP0815735A2 (fr) * 1996-06-27 1998-01-07 Societe Des Produits Nestle S.A. Produit laitier diététiquement équilibré
EP0920813A1 (fr) * 1997-12-08 1999-06-09 Societe Des Produits Nestle S.A. Accélération de la vitesse de digéstion d'une protéine
US20020032234A1 (en) * 1999-06-01 2002-03-14 Drugtech Corporation Nutritional supplements
US6403142B1 (en) * 1998-12-11 2002-06-11 Ralston Purina Company Hypoallergenic pet food
US20030050341A1 (en) * 2001-09-12 2003-03-13 Bydlon Roland J. Vitamin/Mineral Compositions with DHA
EP1302115A1 (fr) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Utilisation de cystathionine
US20040071825A1 (en) * 2002-10-15 2004-04-15 Christopher Lockwood Agglomerated granular protein-rich nutritional supplement
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
FR2860976A1 (fr) * 2003-10-20 2005-04-22 Ravi Shrivastava Nouvelles compositions synergiques pour ameliorer la biodisponibilite et l'efficacite des acides gras polyinsatures pour le traitement des troubles du fonctionnement cerebral.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB806714A (en) * 1956-05-03 1958-12-31 Merck Ag E Improvements in or relating to pharmaceuticals
FR2292437A1 (fr) * 1974-11-27 1976-06-25 Otc Consult Ab Procede pour la preparation d'un aliment pour coquillages et poissons
FR2497068A1 (fr) * 1980-12-27 1982-07-02 Snow Brand Milk Products Co Ltd Composition nutritive adaptee a une alimentation par voie enterale
FR2520232A1 (fr) * 1982-01-22 1983-07-29 Ajinomoto Kk Regime elementaire pour les maladies hepatiques
EP0126666A1 (fr) * 1983-04-20 1984-11-28 Roussel-Uclaf Nouvelles compositions utilisables en diététique, réanimation et thérapeutique, renfermant une fraction protéique à base de 3 types de minipeptides et leurs applications
EP0330583A2 (fr) * 1988-02-26 1989-08-30 L'oreal Méthode pour améliorer l'aspect esthétique de la peau à l'aide de mélanges polyvitaminiques et compositions cosmétiques pour sa mise en oeuvre
US5455235A (en) * 1992-04-10 1995-10-03 Otsuka Pharmaceutical Co., Ltd. Food composition for inhibiting the formation of an intestinal putrefactive product
FR2691616A1 (fr) * 1992-05-27 1993-12-03 Thorel Jean Noel Bio-vecteurs nutritionnels.
FR2706255A1 (fr) * 1993-06-17 1994-12-23 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
EP0689834A2 (fr) * 1994-07-01 1996-01-03 Willem Jacob Serfontein Additif alimentaire pour l'homme ou les animaux contenant des vitamines et des sels minéraux à libération prolongée
EP0815735A2 (fr) * 1996-06-27 1998-01-07 Societe Des Produits Nestle S.A. Produit laitier diététiquement équilibré
EP0920813A1 (fr) * 1997-12-08 1999-06-09 Societe Des Produits Nestle S.A. Accélération de la vitesse de digéstion d'une protéine
US6403142B1 (en) * 1998-12-11 2002-06-11 Ralston Purina Company Hypoallergenic pet food
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
US20020032234A1 (en) * 1999-06-01 2002-03-14 Drugtech Corporation Nutritional supplements
US20030050341A1 (en) * 2001-09-12 2003-03-13 Bydlon Roland J. Vitamin/Mineral Compositions with DHA
EP1302115A1 (fr) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Utilisation de cystathionine
US20040071825A1 (en) * 2002-10-15 2004-04-15 Christopher Lockwood Agglomerated granular protein-rich nutritional supplement
FR2860976A1 (fr) * 2003-10-20 2005-04-22 Ravi Shrivastava Nouvelles compositions synergiques pour ameliorer la biodisponibilite et l'efficacite des acides gras polyinsatures pour le traitement des troubles du fonctionnement cerebral.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LUCHSINGER J A ET AL: "Dietary factors and Alzheimer's disease", LANCET NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, vol. 3, no. 10, October 2004 (2004-10-01), pages 579 - 587, XP004808885, ISSN: 1474-4422 *

Also Published As

Publication number Publication date
FR2886154B1 (fr) 2010-03-26
US20090181974A1 (en) 2009-07-16
WO2006125810A2 (fr) 2006-11-30
EP1890689A2 (fr) 2008-02-27
FR2886154A1 (fr) 2006-12-01

Similar Documents

Publication Publication Date Title
IL186788A0 (en) Nutritional supplement for hiv patients
WO2008081583A1 (fr) Boisson sous emballage
WO2008054200A3 (fr) Utilisation de compositions nutritives pour empêcher des troubles
WO2006068729A3 (fr) Procedes et compositions pour ameliorer l'absorption de fer
WO2005051396A3 (fr) Procedes de reduction des graisses corporelles au moyen de composes de vitamine d
IL164332A0 (en) Compositions comprising dietary fat complexer and methods for their use
WO2005099716A3 (fr) Methode d'analyse de l'age biologique d'un sujet
WO2005004916A3 (fr) Excipient de phosphate de calcium modifie
WO2009037562A3 (fr) Formulations de suppléments nutritifs destinées à être incorporées dans des aliments et aliments enrichis comprenant de tels suppléments
EP2241196A3 (fr) Complément nutritionnel comprenant oligosaccharides et cysteine pour traiter hiv
AR047680A1 (es) Sales amorfas de citrato de calcio solubles en agua y metodo para prepararlas y utilizarlas
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
TW200603746A (en) Iron sulfate based phosphate adsorbent
WO2007056376A3 (fr) Compositions pour reguler des troubles metaboliques et procedes d'utilisation de celles-ci
WO2007064968A3 (fr) Compositions pharmaceutiques stables de 5,10 methylenetetrahydrofolate
WO2006125810A3 (fr) Composition pour retarder le développement de la maladie d'alzheimer
ATE354294T1 (de) Mit calcium angereicherte kleinkindernährmittel auf sojabasis
WO2008120717A1 (fr) Composition nutritionnelle liquide contenant du sodium à une concentration élevée et son procédé de production
WO2005117979A3 (fr) Utilisation de il-17 pour traiter les troubles de la fertilite
WO2007038596A3 (fr) Additifs nutritionnels a base de phytosterol
PL1660097T3 (pl) Kompozycja fizjologicznie czynna na bazie fosfatydyloseryny
PL1753309T3 (pl) Kompozycje spożywcze zawierające kreatynę
EA200800148A1 (ru) Применение фуллерена с60 в качестве стабилизатора масел
PL1527770T3 (pl) Kompozycja maseczki kosmetycznej
MY166221A (en) Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006755300

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2006755300

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11921066

Country of ref document: US